Stem Cell-Derived Signaling Proteins & Growth Factors
Precision-Tailored RPA Therapy: Delivering Superior Signaling Power for Optimal Regenerative Results
If you’ve tried physical therapy, steroid injections, PRP, or even stem cell treatments—with little to no relief—it’s time to consider a next-generation solution that targets the root of joint and soft tissue degeneration at the molecular level.
Regenerative Protein Arrays (RPAs) harness the body’s own language of healing—over 80 unique signaling proteins, including cytokines, growth factors, and miRNA—to reactivate dormant repair mechanisms and restore balance in injured tissues. That’s twice the bioactive content found in traditional amniotic or Wharton’s jelly stem cell products, and far more than PRP or bone marrow aspirate.
Unlike cell-based therapies, RPAs are acellular and immune-neutral, making them safe for everyone, with no risk of rejection or reaction. These signaling proteins are extracted from the most regenerative layers of perinatal tissue, and act like “software” that upgrades your body’s own healing capacity—without surgery or downtime.
Conditions We Commonly Address with RPA Therapy
Knee arthritis and meniscus injuries
Shoulder degeneration and rotator cuff damage
Hip joint wear and tear
Spinal disc degeneration (neck and back)
Foot, ankle, and tendon injuries
Non-healing ligament and cartilage injuries
If You’re Considering Surgery, Try This First.
Don’t give up on your body’s ability to heal. Discover why more physicians are calling RPA therapy the future of regenerative medicine